MedPath

Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Registration Number
NCT00005587
Lead Sponsor
Medical Research Council
Brief Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which regimen of radiation therapy is more effective following surgery for breast cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of radiation therapy following surgery in treating women who have early stage breast cancer.

Detailed Description

OBJECTIVES:

* Determine the benefits of radiotherapy schedules using fraction sizes larger than 2.0 Gy in terms of normal tissue responses, local-regional tumor control, quality of life, and economic consequences in women prescribed postoperative radiotherapy for early stage breast cancer.

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to center, type of surgery (mastectomy vs local excision), and breast boost (yes vs no). Patients are randomized to 1 of 2 treatment arms.

* Arm I: Patients receive radiotherapy 5 times a week for 5 weeks for a total dose of 50 Gy.

* Arm II: Patients receive radiotherapy 5 times a week for 3 weeks for a total dose of 40 Gy.

A breast boost is recommended in both arms for patients with microscopic evidence of invasive or in situ cancer at, or within 1 mm of, a resection margin. These patients receive radiotherapy for 5 fractions in 1 week for a total boost dose of 10 Gy.

Quality of life is assessed at baseline and then at 6, 12, 24, and 60 months.

Patients are followed annually for up to 20 years.

Peer Reviewed and Funded or Endorsed by Cancer Research UK

PROJECTED ACCRUAL: A total of 1840 patients (920 per arm) will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (32)

Royal Sussex County Hospital

🇬🇧

Brighton, England, United Kingdom

Addenbrooke's NHS Trust

🇬🇧

Cambridge, England, United Kingdom

Cheltenham General Hospital

🇬🇧

Cheltenham, England, United Kingdom

Royal Devon and Exeter Hospital

🇬🇧

Exeter, England, United Kingdom

Royal Surrey County Hospital

🇬🇧

Guildford, England, United Kingdom

Ipswich Hospital NHS Trust

🇬🇧

Ipswich, England, United Kingdom

University Hospitals of Leicester

🇬🇧

Leicester, England, United Kingdom

Guy's and St. Thomas' Hospitals Trust

🇬🇧

London, England, United Kingdom

Maidstone Hospital

🇬🇧

Maidstone, England, United Kingdom

Christie Hospital N.H.S. Trust

🇬🇧

Manchester, England, United Kingdom

Scroll for more (22 remaining)
Royal Sussex County Hospital
🇬🇧Brighton, England, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.